PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 2, 2024Cancer Epidemiology Biomarkers & Prevention34 citations

Liver Cancer: Progress and Priorities

View Full Paper
KMKatherine A. McGlynnJPJessica L. PetrickJGJohn D. Groopman

Key Points

Key points are not available for this paper at this time.

Abstract

Liver cancer, the sixth most frequently occurring cancer in the world and the third most common cause of cancer mortality, has wide geographical variation in both incidence and mortality rates. At the end of the 20th century, incidence rates began declining in some high-rate areas and increasing in some lower-rate areas. These trends were undoubtedly driven by the shifting contributions of both well-established and more novel risk factors. While notable strides have been made in combating some major risk factors, such as hepatitis B virus and hepatitis C virus, the emergence of metabolic conditions as important drivers of liver cancer risk indicates that much work remains to be done in prevention. As liver cancer is strongly associated with economic and social deprivation, research, early-diagnosis, and treatment among disadvantaged populations are of paramount importance.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

McGlynn et al. (2024) studied this question.

synapsesocial.com/papers/68e55ef0e2b3180350efc2fdhttps://doi.org/10.1158/1055-9965.epi-24-0686
Ask AI
Helpful
Bookmark
Share
View Full Paper